Figure 1 — Profiling of a novel circadian clock-related prognostic signature and its role in immune function and response to molecular targeted therapy in pancreatic cancer

Research Paper|Volume 15, Issue 1|pp. 119–133

Profiling of a novel circadian clock-related prognostic signature and its role in immune function and response to molecular targeted therapy in pancreatic cancer

Back to articleFigure 1(1 of 6)

100%

Figure 1.Development of a circadian clock-related prognostic signature. (A) Forest plot for 27 genes with a statistical relevance. (B, C) The 27 qualified genes were subsequently fed into LASSO regression model.